Contact Us |







dayanews emp nodaya


 20 | April | 2015

Pluristem’s Clinical Advisory Board Prepares Phase II Clinical Trials in Critical Limb Ischemia in Europe and Japan

Read more >

 24 | March | 2015

Pluristem Announces Key Strategic Objectives for Development of PLX-R18 in Hematopoietic Indications

Read more >

 09 | March | 2015

Pluristem to Present Data at Regenerative Medicine Conferences in Japan and South Korea

Read more >

 03 | March | 2015

Pluristem and Hadassah Medical Center Announce Significant Data Showing PLX-R18 Cells Improve Bone Marrow Transplantation

Read more >

 18 | February | 2015

Significant Findings in U.S. National Institutes of Health’s Trial of Pluristem’s PLX-R18 Cells for Treatment of Acute Radiation Syndrome

Read more >

 2 | February | 2015

Pluristem Announces Significant New Finding from its Phase I/II Muscle Injury Trial and Excellent Safety Profile for PLX-PAD Cells at Twelve Months

Read more >

About hp


Zami Aberman

Zami Aberman

Chairman and CEO

From the CEO


Our vision at Pluristem Therapeutics is to leverage our position as a global leader in placenta-based cell science to develop and manufacture safe and effective cell therapy products. We believe our cutting edge technology can produce therapies that will help people affected by inflammation, ischemia, hematological disorders, and acute radiation syndrome, and establish us as a leading company in the cell therapy arena. We also believe that in cell therapy “the process is the product”, and precise control of the entire process, from obtaining cells from the source, to delivery to the patient, is vital to the success of a cell therapy. Our fully automated process, proprietary 3D cell expansion technology and increasing knowledge of the placental cell drive us to continue developing additional candidates for our product portfolio.


Zami Aberman
Chairman and CEO


Key Strategic Objectives for Development of PLX-R18 in Hematopoietic Indications-  PDF (click here)



Pluristem Video






r18 01

 catom 01

catom 03

catom 05

catom 07

catom 09

catom 11

catom 13




catom 02

Share Button

The content, text, graphics, data, and services offered herein (the "Content") are provided solely to educate users of this web site on Pluristem and the goods and/or services it provides.  Nothing in the Content should be considered, or used as a substitute for, medical advice, diagnosis or treatment.  Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.  Reliance on the Content or any portion thereof, or other visitors to the web site, is solely at your own risk.